These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 26189354)

  • 1. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
    Warnakulasuriya S; Ariyawardana A
    J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral premalignant lesions: from a clinical perspective.
    Amagasa T; Yamashiro M; Uzawa N
    Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked variation in malignant transformation rates of oral leukoplakia.
    Anderson A; Ishak N
    Evid Based Dent; 2015 Dec; 16(4):102-3. PubMed ID: 26680515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.
    Villa A; Celentano A; Glurich I; Borgnakke WS; Jensen SB; Peterson DE; Delli K; Ojeda D; Vissink A; Farah CS
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):64-78. PubMed ID: 31140698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients.
    Hogewind WF; van der Kwast WA; van der Waal I
    J Craniomaxillofac Surg; 1989 Apr; 17(3):128-33. PubMed ID: 2651483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.
    Chuang SL; Wang CP; Chen MK; Su WW; Su CW; Chen SL; Chiu SY; Fann JC; Yen AM
    Oral Oncol; 2018 Dec; 87():58-63. PubMed ID: 30527244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral medicine 8. Leukoplakia of the oral mucosa].
    Schepman KP; van der Meij EH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical determinants of malignant transformation in oral epithelial dysplasia.
    Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
    Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
    Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
    J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
    Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
    J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature.
    Abadie WM; Partington EJ; Fowler CB; Schmalbach CE
    Otolaryngol Head Neck Surg; 2015 Oct; 153(4):504-11. PubMed ID: 26044786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.